Todd Berard - BioLife Solutions Vice President of Marketing

BLFS Stock  USD 20.89  0.08  0.38%   

President

Mr. Todd Berard is the Vice President Marketing of the Company. He is responsible for corporate branding, product branding, marketing and launch strategy, and product management. He is also a key team member in the management and growth of all product launches including biologistex. Before his appointment as Vice President of Marketing, Mr. Berard had served as Senior Director of Marketing since July 2014. Previous to BioLife, Mr. Berard served as Director of Marketing at Verathon Medical a division of Roper Inc., from September 2010 until July 2014, overseeing the global marketing, product development, and product launch strategies for a portfolio of six medical device brands. He also managed all strategic partnerships for product development, and helped guide the organization. Verathon had global sales in 2014 of roughly 180M and Mr. Berard oversaw a creative and product management team of 12. Responsibilities included all global marketing initiatives and campaigns, strategy, product portfolio management, and strategic planning. He has over twenty years of experience in life sciences, health care, and technology working for both global leaders and small technology startups, including the University of Washington School of Medicine, DuPont, and Medtronic. He has a BS Degree in Biochemistry from the University of Vermont and an MBA from the University of Washington Foster School of Business. since 2015.
Age 56
Tenure 10 years
Professional MarksMBA
Phone425 402 1400
Webhttps://www.biolifesolutions.com

Todd Berard Latest Insider Activity

Tracking and analyzing the buying and selling activities of Todd Berard against BioLife Solutions stock is an integral part of due diligence when investing in BioLife Solutions. Todd Berard insider activity provides valuable insight into whether BioLife Solutions is net buyers or sellers over its current business cycle. Note, BioLife Solutions insiders must abide by specific rules, including filing SEC forms every time they buy or sell BioLife Solutions'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

BioLife Solutions Management Efficiency

BioLife Solutions' management efficiency ratios could be used to measure how well BioLife Solutions manages its routine affairs as well as how well it operates its assets and liabilities.
BioLife Solutions currently holds 30.17 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. BioLife Solutions has a current ratio of 3.48, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about BioLife Solutions' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Reginald SeetoCareDx Inc
52
Eldon SchafferAptarGroup
53
Chad CampbellAngioDynamics
54
Craig MalzahnRegenxbio
N/A
Angelo ScopelianosAxogen Inc
68
Randal GoldenThe Cooper Companies,
57
Xiangwei GongAptarGroup
55
David HelselAngioDynamics
60
Robert AuerbachThe Cooper Companies,
58
Daniel McBrideThe Cooper Companies,
56
Erick DeVinneyAxogen Inc
49
Holly SheffieldThe Cooper Companies,
54
Warren NighanAngioDynamics
56
Robert KuhnAptarGroup
63
Hedi TliliAptarGroup
50
Alexander JohnsonCareDx Inc
49
Justin NozneskyAtriCure
47
Agostino RicupatiThe Cooper Companies,
57
Brian AndrewsThe Cooper Companies,
45
Benjamin DavisAngioDynamics
61
Marc PrieurAptarGroup
59
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. Biolife Solutions operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 432 people. BioLife Solutions (BLFS) is traded on NASDAQ Exchange in USA. It is located in 3303 Monte Villa Parkway, Bothell, WA, United States, 98021 and employs 159 people. BioLife Solutions is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

BioLife Solutions Leadership Team

Elected by the shareholders, the BioLife Solutions' board of directors comprises two types of representatives: BioLife Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioLife. The board's role is to monitor BioLife Solutions' management team and ensure that shareholders' interests are well served. BioLife Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioLife Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
Aby Mathew, Chairman of Scientific Advisory Board, CTO and Sr. VP
Sarah JD, Chief Officer
Troy Wichterman, Chief Officer
Geraint Phillips, Senior Operations
Todd Berard, Vice President of Marketing
Karen Foster, Vice President - Operations
Troy CPA, Chief Officer
Sean Werner, Chief Officer
Marcus Schulz, Chief Officer
Michael Rice, CEO and President and Director
Roderick Greef, Interim CFO, Interim Secretary

BioLife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioLife Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.